Hepatic and systemic inflammation markers in patients with type 2 diabetes and NASH: decreased hepatic levels of TNF-alpha and IL-8 as increased severity of NASH

dc.contributor.author	Cevikbas, U.
dc.contributor.author	Satman, I.
dc.contributor.author	Ozel, S.
dc.contributor.author	Tiryaki, B.
dc.contributor.author	Okten, A.
dc.contributor.author	Kocabay, G.
dc.contributor.author	Telci, A.
dc.contributor.author	Tutuncu, Y.
dc.date.accessioned	2021-03-03T15:17:57Z
dc.date.available	2021-03-03T15:17:57Z
dc.identifier.citation	Kocabay G., Satman I., Telci A., Tutuncu Y., Ozel S., Cevikbas U., Tiryaki B., Okten A., "Hepatic and systemic inflammation markers in patients with type 2 diabetes and NASH: decreased hepatic levels of TNF-alpha and IL-8 as increased severity of NASH", 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, Hollanda, 18 - 21 Eylül 2007, cilt.50
dc.identifier.other	vv_1032021
dc.identifier.other	av_3e4237fe-ff3e-44c5-b6f4-726ebdc68f12
dc.identifier.uri	http://hdl.handle.net/20.500.12627/45708
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Endokrinoloji ve Metabolizma Hastalıkları
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ENDOKRİNOLOJİ VE METABOLİZMA
dc.title	Hepatic and systemic inflammation markers in patients with type 2 diabetes and NASH: decreased hepatic levels of TNF-alpha and IL-8 as increased severity of NASH
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	50
dc.contributor.firstauthorID	134168

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.